| 000 | 01767 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516123048.0 | ||
| 264 | 0 | _c20130730 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1555-8576 | ||
| 024 | 7 |
_a10.4161/cbt.22954 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPark, Jae Myung | |
| 245 | 0 | 0 |
_aPrognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. _h[electronic resource] |
| 260 |
_bCancer biology & therapy _cFeb 2013 |
||
| 300 |
_a100-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xgenetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xgenetics |
| 650 | 0 | 4 |
_aAutophagy _xgenetics |
| 650 | 0 | 4 | _aBeclin-1 |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
| 650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSequestosome-1 Protein |
| 700 | 1 | _aHuang, Shengbing | |
| 700 | 1 | _aWu, Tsung-Teh | |
| 700 | 1 | _aFoster, Nathan R | |
| 700 | 1 | _aSinicrope, Frank A | |
| 773 | 0 |
_tCancer biology & therapy _gvol. 14 _gno. 2 _gp. 100-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cbt.22954 _zAvailable from publisher's website |
| 999 |
_c22300946 _d22300946 |
||